Kiblawi Mahmoud A, Hafeez Kashif, Lami Shahed K, Al Teneiji Omar A, Al Mubarak Abdullah N, Swaid Thaer K, Ahmed Sundos A, Alabiri Roaa S, Alabiri Ruba S
Department of Internal Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, ARE.
Department of Endocrinology, Shiekh Shakbout Medical City, Abu Dhabi, ARE.
Cureus. 2022 Mar 19;14(3):e23321. doi: 10.7759/cureus.23321. eCollection 2022 Mar.
Thyroid cancer is the most prevalent endocrine cancer worldwide. It is the second most common type of cancer among United Arab Emirates (UAE) women and ranks as the sixth most common type of cancer overall among the UAE population. There are limited studies in the UAE related to thyroid malignancy. This study aimed to determine the pattern of thyroid malignancy among the UAE population and its associated characteristics, with more emphasis on patients categorized as Bethesda III by cytopathology, and furthermore, to determine the significance of advanced diagnostic methods in the assessment of thyroid nodules.
A retrospective review of the electronic medical charts of adult patients (age 18 and above) who were diagnosed with a thyroid nodule by ultrasound during the years 2019 and 2020. It is a comparative study of different variables associated with thyroid nodules and thyroid malignancy.
A total of 1072 patients were diagnosed with thyroid nodules upon initial ultrasound. We had 174 patients diagnosed with thyroid malignancy, constituting 16% (95% CI 0.14-0.19) of the total study population. 78% of the thyroid malignancy patients were women as compared to men, and this difference was statistically significant (p=0.042). Non-UAE nationals comprised 61% of the population diagnosed with thyroid malignancy (95% CI 1.37-2.68). Malignancy was found to be more common in patients with multinodular goiter, in the 30 to 39-year age group, and in patients with high ultrasound and Bethesda grades. From the total study population, 140 patients had cytology reports in the Bethesda III category. Thyroid malignancy was found in 30 patients with Bethesda III, and this comprised 17% of the total population who were diagnosed with thyroid malignancy.
Despite being a single-center study, it highlights the percentage of thyroid malignancy and its associated factors among the UAE population. Thyroid ultrasound grading and Bethesda classification guide physicians in risk stratification, but it remains challenging in patients who fall into the Bethesda III category. Intervention versus regular follow-up should not depend on a single value but on the overall clinical picture and the use of advanced diagnostic methods.
甲状腺癌是全球最常见的内分泌癌。它是阿拉伯联合酋长国(阿联酋)女性中第二常见的癌症类型,在阿联酋总人口中总体上排名第六常见的癌症类型。在阿联酋,与甲状腺恶性肿瘤相关的研究有限。本研究旨在确定阿联酋人群中甲状腺恶性肿瘤的模式及其相关特征,更侧重于细胞病理学分类为贝塞斯达III类的患者,此外,确定先进诊断方法在甲状腺结节评估中的意义。
对2019年至2020年期间通过超声诊断为甲状腺结节的成年患者(年龄18岁及以上)的电子病历进行回顾性研究。这是一项对与甲状腺结节和甲状腺恶性肿瘤相关的不同变量的比较研究。
共有1072例患者在初次超声检查时被诊断为甲状腺结节。我们有174例患者被诊断为甲状腺恶性肿瘤,占总研究人群的16%(95%CI 0.14 - 0.19)。与男性相比,78%的甲状腺恶性肿瘤患者为女性,且这种差异具有统计学意义(p = 0.042)。非阿联酋国民占被诊断为甲状腺恶性肿瘤人群的61%(95%CI 1.37 - 2.68)。在多结节性甲状腺肿患者、30至39岁年龄组以及超声和贝塞斯达分级较高的患者中,恶性肿瘤更为常见。在总研究人群中,140例患者的细胞学报告为贝塞斯达III类。在30例贝塞斯达III类患者中发现了甲状腺恶性肿瘤,这占被诊断为甲状腺恶性肿瘤总人口的17%。
尽管这是一项单中心研究,但它突出了阿联酋人群中甲状腺恶性肿瘤的百分比及其相关因素。甲状腺超声分级和贝塞斯达分类有助于医生进行风险分层,但对于属于贝塞斯达III类的患者来说仍然具有挑战性。干预与定期随访不应仅取决于单一数值,而应取决于整体临床情况以及先进诊断方法的使用。